Summary of project PR000716

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR000716. The data can be accessed directly via it's Project DOI: 10.21228/M8496H This work is supported by NIH grant, U2C- DK119886.


Project ID: PR000716
Project DOI:doi: 10.21228/M8496H
Project Title:Evaluation of TB Treatment Response Biomarkers
Project Type:Directed MS analysis
Project Summary:Directed MS analysis of promising treatment response biomarkers in TB patient urine.
Institute:Colorado State University
Department:Department of Microbiology, Immunology, and Pathology
Last Name:Fitzgerald
First Name:Bryna
Address:3185 Rampart Rd, Fort Collins, CO, 80521, USA
Funding Source:NIH U01 AI-115619

Summary of all studies in project PR000716

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
(* : Contains raw data)
ST001069 Evaluation of Seryl-leucine core 1 O-glycosylated peptide (SLC1G) in TB patient urine Homo sapiens Colorado State University MS 2018-12-11 1 229 Uploaded data (1.4G)*
ST001104 Seryl-leucine core 1 O-glycosylated peptide (SLC1G) identification Homo sapiens Colorado State University MS* 2019-01-22 1 9 Uploaded data (1.5G)*